Eli Lilly and Company (NYSE:LLY – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold ...

Eli Lilly and Company (NYSE:LLY – Free Report) had its price target reduced by Wells Fargo & Company from $1,000.00 to ...

Eli Lilly and Company discovers ... Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin ...

In 1999, the average list price of Humalog—a brand-name insulin medication manufactured by Eli Lilly—was only $21." "By 2017, the list price of Humalog soared to more than $274—a staggering ...

Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand. The ‘authorised generic’ uses the same insulin lispro ...

Both Humalog and Insulin Lispro Injection are fast-acting ... and less than $8 in the UK. Eli Lilly together with Sanofi and Novo Nordisk make up 90% of the US market for insulin.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Humalog, an injectable, fast-acting insulin to treat diabetes ... where he did his postdoctoral fellowship, for Eli Lilly in Indianapolis. He started as a bench scientist in 1981 working on ...

Eli Lilly's operational performance ... the company's growth during this time. As an example, Humalog, which is a brand name prescription insulin that helps those with diabetes to better manage ...